初诊食管鳞状细胞癌骨转移影像学筛查分析与研究

doi:10.12117/jccmi.2018.11.011

摘要
图/表
参考文献(19)
相关文章 (15)

全文: PDF (0 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要目的：通过对376例初诊食管鳞状细胞癌患者骨转移影像学筛查资料分析，探讨骨转移发生率及骨转移影像学筛查的必要性。方法：回顾性分析2015年3月—2017年6月经病理确诊为食管鳞状细胞癌并行骨转移筛查患者376例，对性别、年龄、肿瘤位置、cT、cN、cTNM、疼痛等临床资料进行统计学分析，评估与骨转移结果相关性。结果：初诊食管鳞状细胞癌骨转移率6.4%（24/376），骨转移组在性别、肿瘤位置、cT、cN、cTNM指标上与骨转移阴性组无统计学差异（P＞0.05）。但在疼痛、高龄、M1分期上具有显著统计学差异（P＜0.05）。多因素二元Logistic回归分析，疼痛、高龄、M1均为骨转移独立预测因子。通过对cT、cN进行亚组分析，Tis-2N0M0期骨转移占总转移例数的29.2%（7/24）。结论：任何cT、cN、cM初诊食管鳞状细胞癌患者均可发生骨转移，应首选骨扫描进行骨转移筛查，尤其是伴有疼痛症状、高龄、远处转移者。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	郑晓东
	张卫民
	侯建彬

关键词 ：肿瘤, 鳞状细胞, 食管肿瘤, 骨肿瘤, 肿瘤转移, 磁共振成像, 正电子发射断层显像术

Abstract：Objective: By analyzing the clinical characteristics of newly diagnosed 376 patients with esophageal squamous carcinoma, to evaluate the incidence of bone metastasis and discuss the necessity of bone scintigraphy for bone metastasis screening. Methods: We retrospectively reviewed the charts of 376 consecutive patients with a pathology diagnosis of esophageal squamous carcinoma in our department between March 2015 and June 2017, and evaluated gender, age, tumor location, TNM staging, and pain. Results: The rate of bone metastasis was 6.4%(24/376), the pain, M1, and agedness were significantly higher(P＜0.05) in positive patients with bone metastasis than negative patients, but no significant difference in gender, tumor location, cT, cN, cTNM staging(P＞0.005). Multivariate binary logistic regression analysis suggested that pain, M1,agedness were independent predictors of bone metastasis. Among 24 patients with bone metastasis, 29.2%(7/24) cases were Tis-2N0M0. Conclusions: For newly diagnosed patients with esophageal squamous carcinoma, bone metastasis may occur in patients with any cT, cN, cTNM and tumor location. Bone scintigraphy was necessary and the first preferred imageological examination for bone metastasis screening, especially for patients with M1, pain and advanced age.

Key words： Neoplasms, squamous cell Esophageal neoplasms Bone neoplasms Neoplasm metastasis; Magnetic resonance imaging Positron-emission tomography

收稿日期: 2017-12-11

PACS:	Ｒ735.1
	R738.1
	Ｒ817.4

通讯作者: 郑晓东，安阳肿瘤医院胸外科，455000。E-mail：18898768@qq.com

作者简介: 郑晓东（1983-），男，河南安阳人，主治医师。E-mail：18898768@qq.com

引用本文:

郑晓东，张卫民，侯建彬. 初诊食管鳞状细胞癌骨转移影像学筛查分析与研究[J]. 中国临床医学影像杂志, 2018, 29(11): 814-817.
ZHENG Xiao-dong, ZHANG Wei-min, HOU Jian-bin. Analysis of bone metastasis screening by radiological examination for newly diagnosed patients with esophageal squamous carcinoma. JOURNAL OF CHINA MEDICAL IMAGING, 2018, 29(11): 814-817.

链接本文:

http://www.jccmi.com.cn/CN/10.12117/jccmi.2018.11.011 或 http://www.jccmi.com.cn/CN/Y2018/V29/I11/814

[1]赵海敏，韩建奎. 99mTc-MDP SPECT/CT扫描对骨转移瘤的诊断价值及所致辐射剂量的研究[D]. 山东大学，2014. [2]甄玉莎，徐文. 18F-FDG PET/CT显像在食管癌治疗后复发转移中的应用价值[D]. 天津医科大学，2016. [3]Li C, Zhang J, Chen S, et al. Prognostic value of metabolic indices and bone marrow uptake pattern on preoperative 18F-FDG PET/CT in pediatric patients with neuroblastoma[J]. Eur J Nucl Med Mol Imaging, 2017, 259(17): 3851-3859. [4]Davila D, Antoniou A, Chaudhry MA, et al. Evaluation of osseous metastasis in bone scintigraphy[J]. Semin Nucl Med, 2015, 45(3): 266. [5]Cornford P, Bellmunt J, Bolla M, et al. EAU-ESTRO-SIOG guidelines on prostate cancer. Part Ⅱ: Treatment of relapsing, metastatic, and castration-resistant prostate cancer[J]. Eur Urol, 2017, 71(4): 630-642. [6]牛晶晶，杨克虎，徐香玖，等. 18F-FDG PET和99mTc-MDP骨扫描对乳腺癌骨转移诊断价值的Meta分析[J]. 复旦大学学报：医学版，2013，9（13）：253-259. [7]Roberts CC, Daffner RH, Weissman BN, et al. ACR appropriateness criteria on metastatic bone disease[J]. Am Coll Radiol, 2010, 7(6): 400-409. [8]陈晓钟. 骨转移瘤的临床研究进展[J]. 中国肿瘤，2006，15（3）：183-186. [9]李俊雄，罗修文，欧阳亮. 核素骨显像对食管癌术后随访的应用价值[J]. 影像诊断与介入放射学，2012，11（1）：3-4. [10]Janssen JC, Meibner S, Woythal N, et al. Comparison of hybrid 68Ga-PSMA-PET/CT and 99mTc-DPD-SPECT/CT for the detection of bone metastases in prostate cancer patients: Additional value of morphologic information from low dose CT[J]. Eur Radiol, 2017, 33(17): 4994-4996. [11]Kitajima K, Fukushima K, Yamamoto S, et al. Diagnostic performance of 11C-choline PET/CT and bone scintigraphy in the detection of bone metastases in patients with prostate cancer[J]. Nagoya J Med Sci, 2017, 79(3): 387-399. [12]朱继庆，杨渤彦，林琳. 食管癌骨转移的临床特征及预后[J]. 中国肿瘤临床与康复，2015，22（11）：1327-1331. [13]Quint LE, Hepburn LM, Francis IR, et al. Incidence and distribution of distant metastasis from newly diagnosed esophageal carcinoma[J]. Cancer, 1995, 76(7): 1120-1125. [14]杨辉，李强，李德宇，等. 食管癌患者骨转移临床特点研究[J]. 医药论坛杂志，2013，34（11）：3-5. [15]马兰，管丹，陈晓锋，等. 18F-FDG PET在食管癌骨转移患者中的临床应用[J]. 成都医学院学报，2015，10（3）：302-306. [16]温虎玲，游金辉，谢建平. 食管癌术后核素骨显像的影像学特征及发生骨骼转移的多因素分析[J]. 实用医学杂志，2011，27（14）：2654-2656. [17]Li SH, Huang YC, Huang WT, et al. Is there a role of whole-body bone scan in patients with esophageal squamous cell carcinoma[J]. BMC Cancer, 2013, 12(1): 328. [18]薛学义，范武林，许宁，等. 无骨转移症状前列腺癌患者免于骨扫描的临床研究[J]. 现代泌尿生殖肿瘤杂志，2014，6（6）：347-355. [19]Goodner JT, Jumbull AD. Bone metastasis in cancer of esophagus[J]. AJR, 1971, 111(2): 357-367.